Ketone Ester D-β-Hydroxybutyrate-(R)-1,3 Butanediol Prevents Decline in Cardiac Function in Type 2 Diabetic Mice

Phung N Thai1, Charles V Miller2, M Todd King3

  • 1Department of Internal Medicine Cardiovascular Medicine University of California Davis CA.

Insights

Ketone ester (KE) supplementation improved heart function in type 2 diabetes by enhancing mitochondrial health and reducing oxidative stress. This dietary intervention shows promise for diabetic cardiomyopathy prevention.

Area of Science:

  • Cardiovascular Research
  • Metabolic Disorders
  • Mitochondrial Biology

Background:

  • Heart failure is a major cause of mortality in type 2 diabetes mellitus (T2DM) patients.
  • Diabetic cardiomyopathy remains a significant clinical challenge with limited therapeutic options.
  • Existing T2DM treatments show minimal efficacy in preventing cardiac complications.

Purpose of the Study:

  • To investigate the effects of elevated D-β-hydroxybutyrate on cardiac function in a T2DM mouse model.
  • To assess the impact of ketone ester (KE) supplementation on mitochondrial metabolism and stress resistance in diabetic hearts.

Main Methods:

  • Type 2 diabetic (db/db) and wild-type mice were fed either a control or a KE-supplemented diet for 4 weeks.
  • Echocardiography was used to evaluate cardiac systolic and diastolic function.
  • Mitochondrial enzyme expression, oxygen consumption, oxidative stress markers, and mitophagy were analyzed.

Main Results:

  • KE diet improved cardiac systolic and diastolic function in db/db mice.
  • KE supplementation enhanced key enzymes in cardiac ketone metabolism and increased mitochondrial oxygen consumption.
  • Mice on KE diet exhibited increased resistance to oxidative stress and enhanced mitophagy, restoring mitochondrial quality control.

Conclusions:

  • Moderate elevation of D-β-hydroxybutyrate via KE supplementation improves cardiac function in T2DM.
  • KE enhances mitochondrial biogenesis, quality control, and stress resistance, offering a potential therapeutic strategy for diabetic cardiomyopathy.